Graft-versus-host disease in lung transplantation: 4 case reports and literature review.
Graft-versus-host disease (GVHD) is uncommon in lung transplant recipients despite the transfer of a significant amount of donor-derived lymphoid tissue and cells. It is associated with significant morbidity and a high mortality rate. We describe 4 cases of GVHD encountered over a 17-year period and review the literature about this peculiar pathology.
Luckraz
Heyman
H
Transplant Unit, Papworth Hospital, Cambridge, UK. heyman.luckraz@papworth-tr.anglox.nhs.uk
Zagolin
Monica
M
McNeil
Keith
K
Wallwork
John
J
D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D006086:Graft vs Host Disease / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D016041:Heart-Lung Transplantation; D006648:Histocompatibility / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016040:Lung Transplantation; D008285:Major Histocompatibility Complex / Q000276:immunology; D008297:Male; D008875:Middle Aged
D007166:Immunosuppressive Agents